"Designing Growth Strategies is in our DNA"

Japan Pharmaceuticals Market Size, Share & Industry Analysis, By Type (Drugs {Prescription & OTC} and Vaccines {Bacterial & Viral}), By Disease Indication (Oncology, Diabetes, Infectious, Cardiovascular, Neurology & Psychiatry, Respiratory, Renal, Obesity, Autoimmune, Ophthalmic, Gastrointestinal, Dermatology, Hematology/Blood, Liver/Hepatology, Genetic, Hormonal/Endocrine, Women’s Health, Reproductive, & Allergies), By Drug Type (Biologics & Biosimilars, and Small Molecules/Conventional Drugs), By Route of Administration, By Age Group, By Distribution Channel, and Country Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113904

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
    3. Pipeline Analysis, By Key Players
    4. Prevalence/Incidence of Key Diseases in Japan
    5. Regulatory Framework In Japan
    6. Reimbursement Scenario in Japan
  5. Japan Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Drugs
        1. Prescription
        2. OTC
      2. Vaccines
        1. Bacterial
        2. Viral
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Diabetes
      3. Infectious
      4. Cardiovascular
      5. Neurology & Psychiatry
      6. Respiratory
      7. Renal
      8. Obesity
      9. Autoimmune
      10. Ophthalmic
      11. Gastrointestinal
      12. Dermatology
      13. Hematology/Blood
      14. Liver/Hepatology
      15. Genetic
      16. Hormonal/Endocrine
      17. Women’s Health
      18. Reproductive
      19. Allergies
      20. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics & Biosimilars
        1. Antibodies
          1. Monoclonal Antibodies (mAbs)
          2. Bispecific Antibodies
          3. Antibody-Drug Conjugates (ADCs)
          4. Others
        2. Vaccines
        3. Peptides/Peptide-Drug Conjugates (PDCs)
        4. Others
      2. Small Molecules/Conventional Drugs
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
      4. Inhalation
      5. Others
    5. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. Japan Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Takeda Pharmaceutical Company Limited
      2. Otsuka Holdings Co., Ltd.
      3. Astellas Pharma Inc.
      4. Eisai Co., Ltd.
      5. DAIICHI SANKYO COMPANY, LIMITED
      6. ONO PHARMACEUTICAL CO., LTD.
      7. Chugai Pharmaceutical Co., Ltd.
      8. Kyowa Kirin Co., Ltd.
      9. Other Prominent Players 
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments (Mergers, Acquisitions & Partnerships, etc.)
    3. Pipeline Analysis, By Key Players
    4. Prevalence/Incidence of Key Diseases in Japan
    5. Regulatory Framework In Japan
    6. Reimbursement Scenario in Japan
  5. Japan Pharmaceuticals Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Drugs
        1. Prescription
        2. OTC
      2. Vaccines
        1. Bacterial
        2. Viral
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Diabetes
      3. Infectious
      4. Cardiovascular
      5. Neurology & Psychiatry
      6. Respiratory
      7. Renal
      8. Obesity
      9. Autoimmune
      10. Ophthalmic
      11. Gastrointestinal
      12. Dermatology
      13. Hematology/Blood
      14. Liver/Hepatology
      15. Genetic
      16. Hormonal/Endocrine
      17. Women’s Health
      18. Reproductive
      19. Allergies
      20. Others
    3. Market Analysis, Insights and Forecast – By Drug Type
      1. Biologics & Biosimilars
        1. Antibodies
          1. Monoclonal Antibodies (mAbs)
          2. Bispecific Antibodies
          3. Antibody-Drug Conjugates (ADCs)
          4. Others
        2. Vaccines
        3. Peptides/Peptide-Drug Conjugates (PDCs)
        4. Others
      2. Small Molecules/Conventional Drugs
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Topical
      4. Inhalation
      5. Others
    5. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. Japan Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Takeda Pharmaceutical Company Limited
      2. Otsuka Holdings Co., Ltd.
      3. Astellas Pharma Inc.
      4. Eisai Co., Ltd.
      5. DAIICHI SANKYO COMPANY, LIMITED
      6. ONO PHARMACEUTICAL CO., LTD.
      7. Chugai Pharmaceutical Co., Ltd.
      8. Kyowa Kirin Co., Ltd.
      9. Other Prominent Players 
Read Less

Figure 1: Japan Pharmaceuticals Market Revenue Breakdown (USD Billion, %), By Type, 2024 & 2032

Figure 2: Japan Pharmaceuticals Market Value Share (%), by Type, 2024 & 2032

Figure 3: Japan Pharmaceuticals Market Value Share (%), by Indication, 2024 & 2032

Figure 4: Japan Pharmaceuticals Market Value Share (%), by Drug Type, 2024 & 2032

Figure 5: Japan Pharmaceuticals Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 6: Japan Pharmaceuticals Market Value Share (%), by Age Group, 2024 & 2032

Figure 7: Japan Pharmaceuticals Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 8: Japan Pharmaceuticals Market Share (%), By Company, 2024

Table 1: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Type, 2019–2032

Table 2: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drugs, 2019–2032

Table 3: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Vaccines, 2019–2032

Table 4: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Disease Indicarion, 2019–2032

Table 5: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Drug Type, 2019–2032

Table 6: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Biologics & Biosimilars, 2019–2032

Table 7: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Antibodies, 2019–2032

Table 8: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Route of Administration, 2019–2032

Table 9: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Age Group, 2019–2032

Table 10: Japan Pharmaceuticals Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2032

Japan Pharmaceuticals Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 130
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports